Figure 1.
Underreporting of treatment-related toxicities by physicians, relative to patients with either advanced stage lung cancer or early-stage breast cancer. Underreporting of toxicities is defined as the proportion of patients with self-reported treatment-associated toxicities in any of the treatment cycles that were not reported at all by their physician. Data are from 3 RCT.45 Reprinted from Di Maio et al44 with permission.
